Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

States square off with opioids whistleblower over payout from $4.7 billion Walgreens settlement

More than two dozen states argue the $4.7 billion Walgreens settlement is for opioid crisis response and not for whistleblower claims, challenging pharmacist T.J. Novak’s recovery bid.

Summary by Ground News
A group of U.S. states is fighting a whistleblower’s bid for a cut of their multibillion-dollar opioid settlement with retail pharmacy giant Walgreens, arguing the deal was negotiated to fund opioid-crisis response and not to reward a private tipster.

1 Articles

ReutersReuters
Center

States square off with opioids whistleblower over payout from $4.7 billion Walgreens settlement

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to D.Thomas@thomsonreuters.com.)

·United Kingdom
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Reuters broke the news in United Kingdom on Thursday, February 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Walgreens icon

Walgreens

US Politics icon

US Politics

Politics icon

Politics

Democratic Party icon

Democratic Party

Republican Party icon

Republican Party

US Economy icon

US Economy

Economy icon

Economy

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal